Search results

  1. W

    Review of the Quality Control Checks Performed by Current Genome-Wide and Targeted-Genome Association Studies on ME/CFS, 2020, Sepulveda et al

    Perez et al is most likely the awful INIM/Klimas team 23andMe study where no quality control was done. https://www.frontiersin.org/articles/10.3389/fped.2019.00206/full The new paper has this quote. I don't remember a limit on MAF of 0.1, but perhaps I'm thinking of the supplemental table they...
  2. W

    Judy Mikovits

    @Ron on the link you provided it shows that the Lo study was retracted Here is the link to the explanation of retraction https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252929/
  3. W

    News from The Netherlands

    Perhaps you want to broaden the thread from the "Netherlands" to "Benelux" to include Belgium and Luxembourg? Your Avatar is showing you are in Belgium and I wouldn't want you missing out ;).
  4. W

    Closed Fred Friedberg (University of Stonybrook) Hydrogen Rich Water; Heart rate variability biofeedback in CFS

    The most interesting thing I've seen was from @Hip on PR who highlighted this paper where it is thought hydrogen rich water stimulates ghrelin release in the stomach Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice https://www.nature.com/articles/srep03273 ghrelin is one...
  5. W

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    Exact same here. Although I've since migrated from cardigans to hoodies ;). I'm actually grateful for this feature to monitor my activity, rather than a step counter that only counts after the first 16 steps or so like other monitors.
  6. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    You did very good sir! I don't think rules here allow posters to name users on other forums so I kept it anonymous. Until you revealed yourself. Feel free to include your post on how you interpreted the paper here, if you want to that is, perhaps it will generate further discussion. And...
  7. W

    OMF to launch clinical trials on Mestinon & Kynurenine, post-COVID19 study

    I hope they are aware that Mestinon is contraindicated in some diseases that could be mistaken as ME/CFS such as slow channel congenital myasthenic syndrome, a genetic disease. https://rarediseases.org/rare-diseases/congenital-myasthenic-syndromes/ It is also the drug implicated in GWI -...
  8. W

    OMF to launch clinical trials on Mestinon & Kynurenine, post-COVID19 study

    We should all remember treatments can have positive as well as negative outcomes. Will OMF explain the proposed benefit of increasing kynurenine, and what the risks are? We've yet to see ANY convincing data for the metabolic trap, two years after work first started!!! There seems to be a lot of...
  9. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    A user on PR made a very interesting point I think it's worth repeating. By using a model cell line of A549 cells which are grown in patient or HC serum means means replication of the work is possible. I remember @Jonathan Edwards discussing on the nanoneedle thread after that paper was...
  10. W

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    I feel the same way. I'm hoping there might be a few more papers to come, perhaps trying to detect certain antibodies such as the peptide array method of this paper. Maybe they can identify something common among responders. Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis...
  11. W

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    I think the step count should be taken with a grain of salt, and referred to as an activity measure. That's okay if you are comparing like with like. The paper describes using SenseWear activity armband. So if you have sufficient arm movement it may count as steps. I've no idea which version of...
  12. W

    Chris Ponting's project to replicate Mark Davis’s remarkable findings of immune activation in ME/CFS (S McGrath blog)

    Here is @Chris Ponting talk from CMRC 2020 conference on the T cell receptor expansion research described by this thread. First results are expected at the end of 2020. They are testing the null hypothesis in blinded samples that there is no difference detected between the four groups of...
  13. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    Can't remember if I posted this or not. What's intriguing about the HSV-1 and H1N1 virus challenges in this paper is that renowned virus hunter Dr. Ian Lipkin and team are heading down a similar experimental path in their ME studies. In Dr. Lipkins talk at the CDC last September he presented...
  14. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    New optical microscopes have become powerful enough to observe mitochondria in real time in 3D and that is bringing new insights. In the past cells had to be fixed to slides and put in an electron microscope to get a good picture, and that process changes the cells. e.g...
  15. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    Using model cell lines means that the experiment is controlled in certain ways (1) U2-OS cells prevent virus replication as they didn't want this effect in the HHV6 experiment (2) A549 - virus naive - no other virus in these cells (3) they are just looking at the effect of what is added to the...
  16. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    The paper did report on the use of a mass spectrometer to look for protein changes on ciHHV6 reactivated U2-OS cells. Unfortunately they did not do that on the other experiments such as with the A549 cells. Hopefully they will extend this work to look at cellular protein changes between cells...
  17. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    Just to be clear with all the talk about PBMC's. Prusty used U2-OS and A549 model cells that you can buy and grow for the experiments as they have specific properties that he used to control the experiment. From Health Rising article The A549 lung carcinoma cells were virus naive and could be...
  18. W

    Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in ME/CFS - 2020 - Schreiner

    That diagram is a bit confusing. It is so easy to miss the "or" which shows they are separate experiments.
Back
Top Bottom